The Readiness of Biosimilars in Multiple Sclero...

By HEOR Staff Writer

September 19, 2024

Introduction In the complex landscape of Multiple Sclerosis (MS) treatment, biosimilars have begun to play a crucial role. These
Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation
Healthy Ageing Index and Assessment of Age-Related Outcomes
Healthcare System Responses to Ageing Populations
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Modifiable Risk Factors for Dementia: Insights from a 15-Year Study
Unlocking the Economic Potential of Healthy Ageing
Impact of Social Support on Quality of Life Among the Elderly
Real-World Walking Behaviours and Early-Stage Heart Failure
A Comparative Study on PRO Symptom Monitoring Approaches
Enhancing Patient Care in Oncology through Remote Patient Monitoring
ABRE Study: Optimising Treatment for Iliofemoral Venous Obstruction
Psoriasis Treatment and Healthcare Resource Utilisation